EcoR1 Capital Fund Qualified, L.P.

EcoR1 Capital Fund Qualified, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in aTYR PHARMA Inc and Kura Oncology, Inc. Over a trading history stretching from 1 October 2017 to 21 December 2018, the count stands at 18 filings.

In open-market terms, that means 10 purchases worth €4.6M on one side and 8 sales worth €2.9M on the other. Purchases outweigh sales by €1.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2019 to date brings 3 purchases and 1 sale.

In size, the median ticket on the buying side is €451k. No cluster: in 8 purchases, no other insider of the company bought within 30 days. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 63% of cases; the median change was +8.4%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 10 January 2019, the filings show an open-market sale worth €310k in Kura Oncology, Inc. The last insider purchase was made public on 10 January 2019, 2,843 days ago. Typically, a trade is published a median of 21 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.